Metabolic risk factors in pediatric stone formers: a report from an emerging economy

Kiran Imran1, Mirza Naqi Zafar2, Uzma Ozair2

  • 1Department of Chemical Pathology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan. kiranimran10@gmail.com.

Urolithiasis
|October 17, 2016
PubMed

Insights

This study identified metabolic risk factors in 98% of pediatric stone formers, highlighting the importance of early detection and metaphylaxis for preventing kidney stones in children.

Area of Science:

  • Pediatric Nephrology
  • Metabolic Disorders
  • Urolithiasis Research

Background:

  • Pediatric kidney stone disease is a growing concern, particularly in emerging economies.
  • Identifying metabolic risk factors is crucial for effective management and prevention of recurrent stone formation in children.

Purpose of the Study:

  • To investigate the prevalence and types of metabolic risk factors in pediatric stone formers in an emerging economy.
  • To analyze these risk factors by gender and age groups (<1-5, 6-10, and 11-15 years).

Main Methods:

  • Prospective enrollment of 250 pediatric patients (age <1-15 years) with kidney stones.
  • Evaluation of demographic data, blood tests, and 24-hour urine analysis for various metabolic parameters (calcium, magnesium, phosphate, uric acid, citrate, oxalate, etc.).
  • Statistical analysis to determine significance (p ≤0.05) and compare risk factors across genders and age groups.

Main Results:

  • Urinary metabolic abnormalities were identified in 98% of the pediatric patients.
  • Key abnormalities included hypocitraturia (82.8%), hyperoxaluria (26.4%), hyperuricosuria (32.8%), and hypercalciuria (20.4%).
  • Younger children (1-5 years) showed higher rates of hyperuricosuria, hyponatriuria, and hypovolemia compared to older children (11-15 years).

Conclusions:

  • Metabolic analysis is highly effective in identifying risk factors in pediatric stone formers.
  • Findings support the implementation of targeted metaphylaxis for both treatment and prevention of kidney stones in children.
  • Understanding age- and gender-specific risk factors can optimize treatment strategies in pediatric urolithiasis.

Related Concept Videos

Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
521
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
690
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
308
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
309
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
626
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
530